Publication | Open Access

Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study

Lymphoid NeoplasiaRituximab BiosimilarOncologyAdvanced Follicular LymphomaReference RituximabPathologyLymphatic DiseaseImmunotherapyMedicineRadiation OncologyCancer Research